Prospective Observational Study to Compare REMS vs NEWS2 for Patients Presenting to the ED With Sepsis
NCT ID: NCT07171918
Last Updated: 2025-09-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2023-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Field Paramedic Application of Sepsis Triage
NCT03870789
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721
Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation.
NCT05953142
Sepsis Early EvaluatioN Through Rapid Ultrasound and veNous Gas Analysis
NCT05787184
Prognostic Accuracy of qSOFA, SIRS, and EWSs for In-hospital Mortality in Emergency Department
NCT05172479
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hence comparing REMs against NEWS2 to determine prognostication value of both scores in sepsis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sepsis patients
Antibiotics, Vasopressors
Both groups are scored on REMS and NEWS2, and then observed closely for the period of hospital stay with regard to ICU stay duration, ventilator days, vasopressor dependent days and total hospital duration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antibiotics, Vasopressors
Both groups are scored on REMS and NEWS2, and then observed closely for the period of hospital stay with regard to ICU stay duration, ventilator days, vasopressor dependent days and total hospital duration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients age \>/=18 years
* Patients who give informed consent for participation in the study.
* Suspicion of sepsis at the time of presentation to ED as per SSC Guidelines 2021
Exclusion Criteria
* Patients referred from other hospitals with diagnosis of sepsis, after initiation of treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Jubilee Mission Medical College and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Reshma Haridas
Junior Resident
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Emergency Medicine, Jubilee Mission Medical College and Research Institute
Thrissur, , India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
38/22/IEC/JMMC&RI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.